;
Stages of realization of NS programme;
6.4.2. , , , ү ү қң , қ ү ү;
6.4.3. ң қ ң;
6.4.4. Ққ.
6.5. қң ә: қң қ ң ү қғ ғ ұ, қ, қ ұғ ұ ә , , ү , ұ .
6.6. Ә:
:
6.6.1. . . .. .: , 2006. . 164-173, 219-267.
6.6.2. Ққ .Ө., ұ Ұ.Ә. ә қ (ә ғ). : , 2009. . 82-98.
6.6.3. Ққ .Ө., Ә .. қ ә . , 2006. . 77-86.
6.6.4. қ ә . .Ө. Ққң . , 2004. . 114-126.
6.6.5. Ққ .Ө., ұ Ұ.Ә. қ - қ ң -ққ ө. : , 2012. 112 .
Қ:
6.6.6. : . / ., , -, . : . . . . ; . . . .- .: -, 2010.
6.7. қ:
6.7.1. () құ ғ:
6.7.1. қң ұқ ұ.
6.7.2. қ 10 ұқ 3 ұқ
6.7.3. қ ә ғ ә
6.7.2. ә ғ құ ғ:
: қ қғ
қ құғ , қ ө | ә | |
ү ү қң |
6.7.3. қ ұқ:
6.7.3.1. ?
6.7.3.2. ң қ?
6.7.3.3. ү ә?
6.7.3.3. қ қ ғ қғ ?
|
|
6.7.3.4. Ққ қ қ ғ қ?
6.7.3.5. ң қ ә қ?
Ү ү ө:
ұқ қ ң қ өң ә қ (ғ ), қ ң ғ ә (100%) ө. | (100%) () , . | Neonatal screening screening all (100%) newborns in a population with the purpose of early (preclinical) diagnosis, treatment and prevention of development of clinical signs of certain common diseases, particularly metabolic diseases. |
ң қ қ ү , , - ү қғ | () , , , , . | Selective screening screening of individuals who are at risk groups, e.g. babies who have birth defects, with the purpose of secondary prophylaxis. |
ң ққ қң қ үң, қ ң құң ұ ұқ қ . | , , , . | Phenylketonuria a disease associated with disturbed metabolism of amino acids, namely phenylalanine, leading to damage of the nervous system. |
ө қ ү қғ ү | , , . | Cystic fibrosis a systemic disease in which organs that produce mucus are affected. |
ң қ . | , . | Congenital hypothyroidism a disease, characterized by disturbance of the function of thyroid gland. |
ө ң, қ ң, ұқ қ . | , , . | Galactosaemia an enzymopathy characterized by disturbed process of carbohydrate metabolism, namely galactose metabolism. |
ү ү қң ө ү үң ұ | , . | Congenital adrenal hyperplasia a group of diseases in which production of cortisol by adrenal glands is abnormal. |
- қ ү ү ң ғ ә қ қғ | - , . | Filter paper a special paper on which a few drops of a newborns blood is applied for laboratory testing. |
|
|
Құ: қ. . .
35-ә қ